CRISPR-Tech's Factsheet February 28, 2026

CRISPR-Tech avatar

CRISPR-Tech
🇬🇧 Stock Smart Portfolio.
780 copiers.
FEBRUARY
+2.73%
YEAR TO DATE
+6%
1 YEAR
+35.07%
5 YEARS
-7.76%
ANNUALIZED RETURN
+9.03%
TRACK RECORD
9.3 years

About CRISPR-Tech

CRISPR technology can be used to edit the genes of various organisms from human beings to crops. This technology can significantly impact almost all walks of life, including the foods we eat and the way we treat diseases.

Biotechnology companies worldwide are pouring hundreds-of-millions of dollars into Research & Development programs related to this technology. At the same time, there are also many M&A deals and partnerships taking place - all with the goal of being the first to utilize this powerful tool to create a better, healthier future for humanity.

CRISPR-Tech Smart Portfolio allocates in stocks, based on eToro's asset universe, of leading firms in the biotech sphere involved with the further application of this revolutionary technology.

The minimum investment amount for this portfolio is $500.

    Smart Portfolio Stats

    Type

    Smart Portfolio

    Copiers

    780

    Assets Under Copy

    $1M-$2M

    Risk Score

    5

    Trades

    No trades during this period.

    Drawdowns

      Worst Drawdowns

      Depth
      Start
      End
      Total months
      -47.27%
      Sep 2021-54
      -30.87%
      Sep 2018Jun 202021
      -13.85%
      Feb 2018Aug 20186
      -11.78%
      Feb 2021Jun 20214
      -6.55%
      Sep 2020Nov 20202
      -6.29%
      Oct 2017Jan 20183
      -5.12%
      Jul 2021Aug 20211
      -2.37%
      Apr 2017Jun 20172
      -1.21%
      Jul 2020Aug 20201
      -0.58%
      Jul 2017Aug 20171

      Performance Metrics

      Score 3.7/10

      Beta

      1.04
      1.04
      0
      0.8
      1.2
      0
      2

      Sharpe Ratio

      0.37
      0.37
      0
      0.5
      1
      1.5
      1.5

      Sortino Ratio

      0.63
      0.63
      0
      1
      2
      3
      3

      Jensen's Alpha

      -1.94
      -1.94
      -2
      0
      2
      4.5
      4.5

      Omega Ratio

      0.95
      0.95
      0
      1
      1.5
      2.5
      2.5

      Treynor Ratio

      0.79
      0.79
      0
      0.75
      1.25
      2
      2

      Information Ratio

      -0.07
      -0.07
      -1
      0.3
      0.6
      1
      1

      Calmar Ratio

      0.19
      0.19
      0
      0.3
      0.6
      1
      1

      Diversification

      Sectors Breakdown

      • Sector
      • Total
      • 🧬 Health Technology
        97.02%
      • 💼 Commercial Services
        2.7%
      • 💵 Cash
        0.29%

      Exchanges Breakdown

      • Exchange
      • Total
      • 🇺🇸 Nasdaq
        83.31%
      • 🇺🇸 NYSE
        16.42%

      Countries Breakdown

      • Country
      • Total
      • 🇺🇸 United States
        80.48%
      • 🇩🇰 Denmark
        4.04%
      • 🇨🇭 Switzerland
        3.68%
      • 🇬🇧 United Kingdom
        3.49%
      • 🇫🇷 France
        3.28%
      • 🇸🇬 Singapore
        3.27%
      • 🇳🇱 Netherlands
        1.48%

      Dividends

      Dividend Yield

      0.75%

      8 out of 30 instruments pay dividend.

      0 dividend payments in the next 30 days.

      Highest Dividend: $PFE (6.48%)

      Dividend Yield Breakdown

      Instrument
      Portfolio Yield
      Company Yield
      Per Share
      PFE
      PFE
      0.23%
      6.48%
      $1.66
      BMY
      BMY
      0.15%
      4.05%
      $2.34
      SNY
      SNY
      0.11%
      3.46%
      $1.48
      AMGN
      AMGN
      0.1%
      2.57%
      $8.76
      JNJ
      JNJ
      0.08%
      2.13%
      $4.81
      AZN
      AZN
      0.05%
      1.57%
      $1.42
      REGN
      REGN
      0.02%
      0.46%
      -
      TMO
      TMO
      0.01%
      0.35%
      $1.48

      Next Dividends

      Stock
      Type
      Date
      Pay Per Share

      Portfolio Holdings

      (As of February 28, 2026)

      Monthly Returns

      Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk. Past performance is not an indication of future results